Jiang, Beibei
Zhang, Tong
Deng, Minjuan
Jin, Wei
Hong, Yuan
Chen, Xiaotong
Chen, Xin
Wang, Jing
Hou, Hongjia
Gao, Yajuan
Gong, Wenfeng
Wang, Xing
Li, Haiying
Zhou, Xiaosui
Feng, Yingcai
Zhang, Bo
Jiang, Bin
Lu, Xueping
Zhang, Lijie
Li, Yang
Song, Weiwei
Sun, Hanzi
Wang, Zuobai
Song, Xiaomin
Shen, Zhirong
Liu, Xuesong
Li, Kang
Wang, Lai
Liu, Ye
Article History
Received: 14 October 2022
Accepted: 6 March 2023
First Online: 25 September 2023
Compliance with ethics guidelines
: <b>Conflicts of interest</b> Beibei Jiang, Tong Zhang, Minjuan Deng, Wei Jin, Yuan Hong, Xiaotong Chen, Xin Chen, Jing Wang, Hongjia Hou, Yajuan Gao, Wenfeng Gong, Xing Wang, Haiying Li, Xiaosui Zhou, Yingcai Feng, Bo Zhang, Bin Jiang, Xueping Lu, Lijie Zhang, Yang Li, Weiwei Song, Hanzi Sun, Zuobai Wang, Xiaomin Song, Zhirong Shen, Xuesong Liu, Kang Li, Lai Wang, and Ye Liu have ownership interest in BeiGene.
: All procedures involving primary human T cells, DCs and PBMCs were reviewed and approved by the Institutional Review Board (IRB) at BeiGene. All experiments involving animals were approved by the Animal Care and Use Committee of BeiGene according to the guidelines of the Chinese Association for Laboratory Animal Sciences (BeiGene IACUC; IACUC No. 2019123)